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Stlmmary 
Tumor necrosis factor ot (TNF-c0, a cytokine with pleiotropic biological effects, is produced 
by a variety of cell types in response to induction by diverse stimuli. In this paper, TNF-c~ mRNA 
is shown to be highly induced in a murine T  cell clone by stimulation with T  cell receptor 
(TCK) ligands  or by calcium ionophores alone. Induction is rapid,  does not require de novo 
protein synthesis, and is completely blocked by the immunosuppressant cyclosporin A (CsA). 
We have identified a human TNF-c~ promoter element, g3, which plays a key role in the calcium- 
mediated inducibility and CsA sensitivity of the gene. In electrophoretic mobility shift assays, 
an oligonucleotide containing K3 forms two DNA protein complexes with proteins that are present 
in extracts from unstimulated T cells. These complexes appear in nuclear extracts only after T 
cell stimulation. Induction of the inducible nuclear complexes is rapid, independent of protein 
synthesis, and blocked by CsA, and thus, exactly parallels the induction of TNF-ot mRNA by 
TCR ligands or by calcium ionophore. Our studies indicate that the K3 binding factor resembles 
the preexisting  component of nuclear factor of activated T cells. Thus, the TNF-c~ gene is an 
immediate early gene in activated T cells and provides a new model system in which to study 
CsA-sensitive gene induction in activated T  cells. 
T 
he human TNF-o~ gene encodes a cytotoxic protein with 
diverse biological activities including the ability to pro- 
mote T and B cell growth (1-8 and for reviews see references 
9-11). TNF-ot is produced by multiple cell types including 
lymphocytes after viral infection or stimulation through cell- 
surface receptors  (12-19).  In primary T  cells for example, 
TNF-c~ mRNA is induced upon stimulation with the phorbol 
ester (PMA) plus activating antibodies to CD3 polypeptides 
(12), which are closely associated with the TCR.  TNF-c~ 
mRNA is also induced in T cells by stimulation with PMA 
alone (12, 18), and by PMA plus calcium ionophore (12, 15), 
which mimics stimulation through the TCR-CD3 complex 
(for reviews see references 20 and 21). 
The promoter sequences required for virus, LPS (16), PMA 
(18, 22-25), and TNF-c~ induction (26) of the human TNF-o~ 
gene have been identified. These studies have yielded a com- 
plex picture of TNF-c~ gene regulation in that the promoter 
sequences required for inducibility have varied with the cell 
type and stimulus studied. Although the 5' flanking region 
of the human TNF-ot gene contains three sequences, ir  K2, 
and 1r  that match the consensus sequence for a binding site 
for the transcription factor NF-r,B, the induction of the human 
TNF-ot gene by virus, LPS, or PMA in the cell lines studied 
does not appear to be primarily mediated by NF-Jcb (16, 18). 
Thus, in contrast to the NF-gB-mediated inducible transcrip- 
tion of other promoters containing NF-IcB binding sites (for 
a review see reference 27), and in contrast to studies with 
the murine TNF-a gene in which NF-gB binding sites have 
been implicated in LPS induction in macrophages (28, 29), 
studies of the human TNF-cr  gene promoter argue against 
a major role for NF-KB in the virus, LPS, or PMA induction 
of the gene (16, 18). 
The immunosuppressive agents cyclosporin A (CsA) 1 and 
FKS06, inhibit the transcription of many cytokine genes in 
activated T cells (15, 30-32). CsA and FK506, when com- 
plexed to their intracellular receptors (cyclophilin and FKBP, 
respectively), bind to and inhibit the activity of the calcium- 
and calmodulin-dependent phosphatase calcineurin (33; for 
reviews see references 34 and 35). Recent studies (36-39) have 
suggested  that calcineurin regulates  the activity of at least 
two elements in the IL-2 gene promoter, nuclear factor of 
activated T cells (NFAT) and NHL2A. The nuclear factors 
binding to these two elements appear to be distinct: the NFAT 
1  Abbreviations used in this  paper: CAT, chloramphenicol acetyl transferase; 
CsA, cyclosporin A; n, nudeotide;  NFAT, nuclear factor of activated T 
cells; OAP-40, octamer-associated protein. 
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consists of a preexisting DNA-binding subunit (NFATp) in 
association with los and jun proteins (41-43), whereas the 
NFIL2A site binds oct-1 and oct-2 proteins in association 
with an inducible octamer-associated protein, OAP-40 (44). 
Calcineurin may directly dephosphorylate NFATp (45), how- 
ever its effect on the activity of the Oct-OAP complex may 
be more involved. 
Using an untransformed murine T cell clone that responds 
to stimulation with antigen and TCR ligands (46, 47), the 
TNF-o~ gene is shown to be one of the earliest  genes tran- 
scribed after T cell activation. Induction of TNF-ol mRNA 
does not require de novo protein synthesis but is sensitive 
to CsA. Thus, the TNF-cr gene represents a new model system 
in which to study CsA-sensitive  gene induction. We have 
identified a TNF-a promoter dement, K3, as a CsA-sensitive 
regulatory element required for TNF-o~ gene transcription 
in activated T  cells. The requirements for induction of the 
It3 binding factor paraUd dosdy the requirements for induc- 
tion of endogenous routine TNF-a  mRNA levels:  both 
TNF-a mRNA and the ~3 binding factor are rapidly induced 
by TCR ligands or by calcium ionophore alone.  Their in- 
duction does not require de novo protein synthesis and is 
blocked by CsA.  Our studies indicate that the nuclear K3 
binding factor is present in unstimulated T cells and that it 
resembles  the preexisting component of NFAT. Activation 
of the x3 binding factor appears to require posttranslational 
modification  and/or translocation to the nucleus via a calcium- 
dependent, CsA-sensitive  pathway. 
Materials and Methods 
Cell Culture, Activation, and Transfections.  The murine IL-2-de- 
pendent T cell clone At-5 (48) was grown and activated  with mAbs 
to murine CD3e (145-2Cll; oLCD3)  or to a framework  determinant 
of the routine TCI~.-r  (H57-597; TCR-cr  for the times indi- 
cated in the figure legends as previously  described (49). Ionomycin 
(Calbiochem-Novabiochem Corp., La Jolla, CA) inductions were 
carried out at 100 nM or 1 #M as indicated in the figures for 30 
min. Where indicated, cells were treated with 10/~M cydohexi- 
mide and 40/~M anisomycin  (both from Sigma Chemical Co., St. 
Louis, MO) for 30 min or with 1/~M CsA (Sandoz, Vienna, Aus- 
tria) before the addition of antibodies or ionomycin. The ability 
of cydoheximide and anisomycin  to block protein synthesis under 
these conditions was verified  by testing the effect  of these reagents 
on the expression of the EBV lyric switch gene, BZLF1, whose 
transcription is dependent on de novo protein synthesis  (50). Tram- 
feetions were performed as described (47) and cells were activated 
the next day with aCD3 or ionomycin and harvested ~18 h later. 
Chloramphenicol acetyl transferase (CAT) assays  were performed 
as previously described (18). 
RNA Analysis.  RNA was prepared from Ar-5 cells as previ- 
ously described (51). 32P-labeled RNA probes were prepared from 
SP6 ~/-actin  (52) and a routine TNF-o~  probe as previously  described 
(16, 51). RNA fragments  protected from RNase cleavage  were sepa- 
rated by eleetrophoresis on a 6% denaturing polyacryhmide gel. 
Preparation  of  Cellular  Extracts and EMSAs.  Nuclear  extracts  were 
prepared as previously  described  (49). To prepare cytosolic  extracts, 
unstimulated At-5 cells were harvested by centrifugation, washed 
with PBS and resuspended and lysed at a concentration of 2.5  x 
107 cells/ml in a buffer containing 50 mM NaCI, 20 mM Tris, pH 
7.5, 10 mM iodoacetamide, 2 mM PMSF, 0.1 mM EDTA, 25 #M 
leupeptin, 100 #g aprotinin, and 0.05%  NP-40. The cells were 
first centrifuged at 200 g to remove nuclei, and then centrifuged 
further at 100,000 g for 60 min. The 100,000 g superuatant was 
then adjusted to a concentration of 1.5 M ammonium sulfate, 
and the predpitated proteins were collected by centrifugation at 
10,000 g. The protein pellets were resuspended in a buffer con- 
taining 100 mM NaCI, 20 mM Hepes, pH 7.4, 10 mM iodoaceta- 
mide, 2 mM EDTA, 2 mM PMSF, 25 gM leupeptin, 100 gg/ml 
aprotinin, and 10% glycerol, and were extensively  dialyzed against 
the same buffer without iodoacetamide and with 0.5 mM DTT. 
EMSAs using nuclear proteins were performed using ,,05 gg 
nuclear protein in a total volume of 15/~1 containing 4 mM Hepes, 
pH 7.4, 90 mM NaC1, 20 mM KC1, 0.08 mM EDTA, 9% glycerol, 
133/~g/ml poly (dl:dC), and 0.125 ng 3ZP-labeled oligonucleotide. 
For competition assays, a 200-fold  excess of  unlabeled oligonudeo- 
tide was added to the reaction. Binding reactions were incubated 
on ice for 15 min. Unbound oligonucleotide and protein-oligonu- 
cleotide complexes were separated by electrophoresis at 4~  on 
Tris/borate/EDTA/4%  acrylamide gels as described earlier (49). 
Cytosolic extracts (0.5-1 ~g protein) were assayed for DNA 
binding in a reaction mix containing 4 mM Hepes, pH 7.4, 100 
mM NaC1, 9% glycerol, 0.7 mg/ml BSA, 17/~g/ml poly (dl:dC), 
and 0.125 ng 3Zp-endlabeled oligonucleotide, followed by elec- 
trophoresis under the same  conditions  described  for nuclear  extracts. 
Methylation interference  assays  were performed  as described  (49). 
The sequences of the synthetic oligonucleotides used in the gel 
shift and methyhtion interference assays  were as follows: K3, (5'- 
GATCCGAGCTCATGGG~CACA-3'); K1, (5'-GATCCT- 
~CAGCCCA-Y); K2, (5'-GATCC~~CA-Y);  NF-xB 
(WT),  (5'-CAGAGGC~ACTTTCCGAGA-Y);  NF-KB (M5'), 
(5'-CAGAATTCACTTTCCGAGA-Y); NF-xB (MY), (5'-CAG- 
AGGGGACTTGAAGAGA-Y); NFAT, (5'-CTGTATCAAACA- 
AATTTTCCTCTTTGGGC-3');  -62  to  -27  nucleotides (n): 
(5'-GATCCGATTCTTTCCCCGCCCTCCTCTCGCCCCAGA- 
GAC-Y); Sp1 M, (5'-AATG~CGAAGCCTCCTCTCG- 
CCC-Y);  and AFI, (5~ 
Plasmids.  The TNF-c~ promoter/CAT gene constructs and the 
-61 TNF-cr CAT and (~3)6-61 TNF-ot CAT constructs have been 
previously described (16). The g3 mutant constructs were con- 
structed by subeloning  a TNF~ promoter fragment into M13mp18 
and performing in vitro mutagenesis  with a Mutagene M13 in vitro 
Mutagenesis Kit (Biorad Laboratories, Richmond, CA). Mutants 
were confirmed by dideoxy sequencing. Promoter sequences from 
-199 to +87 nucleotides  relative to the TNF-~ transcription start 
site were amplified  by PCR and were subeloned into the POCAT 
vector (53) and reconfirmed by sequencing. The wild-type  -199 
to + 87 TNF-c~ sequences were also subeloned in this manner, in- 
suring that all of the constructs were isogenic. 
Results 
Regulation of the Endogenous  Murine  TNF-ot Gene in the 
Murine  T  Cell Clone, Ar-5 
TCR Stimuli.  To characterize the transcriptional induc- 
tion of the TNF-o~ gene in activated T  cells, the untrans- 
formed murine T cell clone, At-5, was stimulated with anti- 
bodies directed towards the CD3 complex (cr  or the 
TCR-cc/fl  (TCR-o~). TNF-o~ mRNA levels were increased 
strikingly within 30 rain of stimulation by either c~CD3 or 
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TNF-ot  gene  expression  in murine  Ar5 T cells. Cells  were 
induced with  anti-CD3  (otCD3)  or  anti-TCR-c~/3 
(otTCR) for 30 min or 4 h as indicated, in the presence 
or absence  of  cydosporin  A (C_aA)  or cyclo~de (C/D  0 
and anisomycin (ANI)  as described in Materials and 
Methods. RNase  mapping  of  TNF-ot  and 3'-actin  mRNA 
was carried out with 5 gig of total cellular  RNA. A 32p. 
labeled mouse TNF-ot probe was used to map murine 
TNF-ot mRNA levels and an RNA probe complemen- 
tary to the 'y-act-in  gene was used as an internal control 
for mRNA levels  as previously  described  (15).  The 3,-actin 
probe was made to have asp act one fifth of the mouse 
TNF-ot probe. (Left)  Positions  of  the TNF-tx  and 3,-actin 
protected fragments. 
by TCK-a (Fig.  1, lanes 4 and 7). This burst-in mRNA ex- 
pression after c~CD3 or TCK-ot induction was associated with 
TNF-ot protein production as determined by TNF-ot bioac- 
tivity in an L cell killing assay (data not shown), indicating 
that Ar-5 ceUs are a physiological system in which to study 
TNF-a gene induction by immunological stimuli. Induction 
of TNF-c~ mRNA levels was blocked by pretreatment of the 
cells with CsA for 10 min before the addition of stimulus 
(Fig.  1, lanes 5 and 8), but not by pretreatment of the cells 
with  the  protein  synthesis  inhibitors  cycloheximide and 
anisomycin (Fig.  1,  lanes  6  and 9).  Expression of TNF-cr 
mRNA at 4 h after activation was also unaffected by protein 
synthesis inhibitors but sensitive to CsA (Fig.  1, lanes 10-18). 
Thus, induction of TNF-ot gene expression by TCR stimuli 
was not dependent upon de novo protein synthesis and hence 
can be differentiated from the induction of mKNAs encoding 
other CsA-sensitive genes such as IL-2 in activated T  cells 
(40). In a related study, TNF-c~ gene expression in activated 
B ceUs has been shown to occur within 30 rain of activation, 
does not require protein synthesis, and is sensitive to CsA 
(19). Thus, the TNF-c~ gene behaves as a CsA-sensitive early 
response gene during activation of both T and B lymphocytes. 
Ca  2§ Ion~hor~  Stimulation of T cells through the TCR 
results in an increase in intracellular free calcium levels and 
activation of protein kinase C,  and can be mimicked with 
a combination of calcium ionophore and phorbol esters (for 
a review see reference 21). CsA is known to inhibit the calcium- 
dependent pathway of T ceU activation by inhibiting the ac- 
tivity of the calcium- and calmodulin-dependent phospha- 
tase calcineurin (33). Since the induction of TNF-c~ mRNA 
in activated T cells was completely sensitive to CsA (Fig. 1), 
it seem probable that a calcium-dependent pathway was in- 
volved. To determine whether calcium flux in the absence 
of  protein kinase C activation was sufficient to induce TNF-c~ 
mRNA levels, At-5 cells were stimulated with the calcium 
ionophore ionomycin. TNF-cr mRNA levels were highly in- 
duced within 30 min after stimulation with 1 #M ionomycin 
(Fig.  2 A, hne 5  and Fig.  2 B, lane 2).  Furthermore, this 
induction was blocked by CsA (Fig.  2 A,  lane 7 and Fig. 
2 B, lane 3), and was unaffected by protein synthesis inhibi- 
tots (Fig. 2 B, lane 4). Furthermore, like CsA,  FK506 was 
able to block the transcriptional induction of TNF-ot mRNA 
in At-5 cells stimulated with c~CD3 or ionomycin (data not 
shown). 
Identification of Promoter Elements Necessary for 
Transcriptional Induction and CsA  Sensitivity 
TCR Stimuli.  To identify the promoter elements required 
for the induction and CsA  sensitivity of TNF-ce gene ex- 
pression, a human TNF-c~ 5' promoter deletion series fused 
to the CAT reporter gene (described in reference 16) was trans- 
Figure 2.  Ionomycin  induction of TNF-a gene expression  in murine 
Ar-5 T cells. (A) Cells were mock (-) induced, induced  with 100 nm 
or 1 pM ionomycin  for 30 or 60 min in the presence  or absence  of 1/zM 
CsA as indicated.  CsA was added 10 rain  before  induction  with ionomycin. 
(B) Cells were mock (-) induced or induced for 30 min with 1 /zM 
ionomycin  alone or in the presence of CsA or CHX and ANIS as indi- 
cated. CsA and CHX/ANIS were added 10 and 30 min, respectively,  be- 
fore induction with ionomycin.  RNase mapping of TNF-c~  and 7-actin 
mRNA was carried  out as described  in the legend  to Fig. 1. (Left)  Posi- 
tions of the TNF-ot  and 3"-actin  protected  fragments. CsA or CHX plus 
ANIS have  no effect  on constitutive  TNF-ot  mRNA expression  (see Fig. 
1, lanes I and 2 and I0 and I1). 
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gene fusions in At-5 T cells. Autoradiogram shows results 
of CAT assays of extracts prepared from At-5 cells trans- 
fected with 5' deletion  constructs  of the human TNF- 
odCAT reporter gene fusions diagrammed in the figure. 
Cells were transfected and mock induced (-) or induced 
with ~CD3 (+) for 18 h in the presence or absence of 
CsA as indicated. CsA was added 10 min before aCD3. 
A promoterless CAT construct (Pocat) showed no activity. 
(Diagram) Positions of three NF-KB  binding  sites (~1, K2, 
and It3) relative to the deletion endpoints and the tran- 
scription start site. (B) A histogram depicting the percent 
conversion  of  [14C]chloramphenicol to  its  acetylated 
forms quantified by a betascope (Betagen, Waltham, MA) 
of the experiment displayed in (A). The experiment dis- 
played is representative of four independent transfection 
experiments. 
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otCD3 in the presence  and  absence of CsA.  This  series of 
plasmids contains progressive deletions of each of  the loB-like 
binding sites (gl, g2, and g3) in the TNF-c~ promoter (dia- 
gram, Fig. 3 A), and thus can be used to evaluate the func- 
tional contribution of these sites to TCtL-mediated  activa- 
tion and CsA sensitivity of the gene. The TNF-c~ CAT fusion 
construct containing  -600 n relative to the TNF-c~ mRNA 
cap site was highly inducible  by c~CD3 and this induction 
was effectively blocked when the cells were pretreated  with 
CsA (Fig. 3 A, lanes 1-3). Deletion of K1 which lies between 
the sequences spanning  -600 and  -576, or deletion of K2, 
which lies between the sequences  -242 and  -199 n,  had 
little effect on the promoter's inducibility by cr  or its 
sensitivity to CsA (Fig.  3 A, lanes 4-12).  Deletion of the 
sequences between  -199 and  -118 n reduced the absolute 
values of both basal and induced CAT activity (Fig.  3 A, 
lanes  13-15).  However, the promoter's inducibility is not 
affected by the deletion of these sequences, and the - 118 de- 
letion construct was still sensitive to CsA (see Fig. 3 B). We 
conclude that the sequences between -199 and  -118 n con- 
tain a positive regulatory region that is required for maximal 
levels of induction of a linked CAT reporter gene by c~CD3. 
In contrast, deletion of the sequences between  -118 and 
-80 n,  which removes the g3 element,  almost eliminated 
otCD3 inducibility and CsA sensitivity  of the TNF-c~ gene 
(Fig. 3 A, lanes 13-18,  and see Fig. 3 B). Further deletion 
of the TNF-c~ promoter to  -52 n relative  to the mRNA 
cap site had no additional  effect (Fig. 3, lanes 19-2I),  indi- 
cating that the sequences lying between - 52 and  + 89 n rel- 
ative to the TNF-ot mRNA cap site are sufficient for basal 
activity and minimal inducibility. In conclusion, the sequences 
between -118 and  -80 n contain a CsA-sensitive promoter 
element that is involved in c~CD3 inducibility of the gene. 
Ca  2+ Ionophore.  The same TNF-c~ 5' promoter deletion 
series was tested in cells induced with calcium ionophore alone 
As shown in Fig. 4, the - 199 TNF-c~ CAT fusion construct 
was highly inducible  by ionomycin and this induction was 
blocked by CsA (lanes I-3).  The level of induction with 
ionomycin was roughly equivalent  to the level of induction 
obtained with c~CD3 (compare Fig. 4, lanes I3-15 to lanes 
1-3).  As previously noted with otCD3, deletion of the se- 
quences between  -199 and  -118 resulted  in a marked de- 
crease in the absolute levels of CAT activity,  however,  the 
decrease in activity was much more pronounced in the case 
ofionomycin induction (compare Fig. 4, lanes 1-6 with Fig. 
3 A, lanes I0-15). Nevertheless, the - 118 construct was dearly 
induced  by ionomycin treatment  and  this  induction  was 
blocked by CsA (Fig. 4, lanes 4-6). When the sequences be- 
tween -118 and  -80, which contain the r,3 site, were deleted, 
induction by ionomycin was no longer detectable (lanes 7-9). 
Deletion of the sequences between - 600 and  - 199 had no 
effect on the ionomycin inducibility of the TNF-ot promoter 
(data not shown). In conclusion,  these results indicate  that 
the sequences  between - 199 and + 89 n relative to the TNF-c~ 
start site mediate induction of the gene by both TCR ligands 
and calcium ionophore,  and that the sequences between - 118 
Figure 4.  Ionomycin induction of human TNF-~/CAT gene fusions 
in At-5 T cells. Autoradiogram  shows results of CAT assays of extracts 
prepared  from At-5 cells transfected  with the 5' deletion constructs  of 
the human TNF-cdCAT constructs diagrammed in Fig. 3. Cells were trans- 
fected and mock induced  (-) or induced  with 1 #M ionomycin (Iono) 
or c~CD3 for 18 h in the presence (+) or absence (-) of CsA as indicated. 
CsA was added 10 min before ionomycin induction. Deletion of the se- 
quences between -600 and  -199 relative to the TNF-c~ cap site did not 
affect constitutive or ionomycin-induced  levels of CAT activity (data not 
shown).  The results are representative of three independent  experiments. 
and  -80 are also required  for inducibility and CsA sensi- 
tivity in the case of both inducers. 
The/c3  Site  Functions as an Inducible, CsA-sensitive 
Transc@tional Element In  Vivo  within  the  Context 
of the  TNF~Promoter 
The significant  drop in inducibility and CsA sensitivity 
of the TNF-c~ promoter seen upon deletion of the sequences 
between - 118 and  - 80 suggested that these sequences con- 
tained  an otCD3 and calcium-inducible,  CsA-sensitive pro- 
moter element. The region defined by this deletion contained 
the previously characterized KB-like  binding site, g3, and its 
surrounding sequences (spanning  -106 to  -87 nt relative 
to the TNF-ot transcription  start site) (18). To determine the 
importance of these sequences, (referred to as K3 or the K3 
element throughout this paper),  and to evaluate its in vivo 
function within the context of the TNF-ot promoter during 
T cell activation,  TNF-ot promoter CAT fusion genes with 
base substitution mutations in the g3 site were constructed. 
These mutations named 5', middle, 3', and 3' flank are depicted 
in Fig. 5 C. They were created in the context of the  -199 
TNF-ol promoter (WT) and are all isogenic except for the 
base changes  noted. 
TCR Stimuli.  Mutation of any of the nucleotides within 
the NF-gB consensus motif of the g3 site caused a reduction 
in the relative induction of CAT activity in response to otCD3 
stimulation of transiently  transfected  At-5 cells. Mutations 
in the 5' or 3' ends of the site reduced the induction,  of CAT 
activity to "~28%  (5' M) and 44% (3' M), respectively, of 
the level of induction seen with the WT plasmid (Fig. 5 A). 
The effect of mutating the middle nucleotides (MM), was 
more modest, decreasing induction to "~70% of WT levels. 
In contrast, mutation of the nucleotides  flanking the 3' end 
of the g3 site (3' flank M), did not decrease induction of CAT 
activity, but rather caused a slight increase in the average level 
of induction ('~116% of WT induced levels). These results 
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Figure  5.  The relative activity of human TNF-oL  CAT fusion constructs 
containing mutations in the K3 or Spl sites (diagrammed  in Fig.  6 C) 
in Ar-5 cells induced with ~CD3 or ionomycin. The K3 rite-directed mu- 
tations  (5'M, MM, 3'M, and 3'flank M) and the Spl mutation (Sp1 M) 
were introduced into the K3 site within the context of the unmutated wild- 
type  -199 TNF-a  promoter  (WT) CAT fusion construct  as described 
in Materials and Methods.  (A) The K3 site participates in CsA-sensitive 
c~CD3 induction of the human TNF-c~ promoter in Ar-5 cells. Cells were 
transfected with the WT and mutated TNF-c~ promoter  CAT plasmids 
and 24 h later were mock induced (unstiraulated) or induced with o~CD3 
(stimulated) for 18 h in the presence or absence of CsA as indicated.  CsA 
was added 10 rain before activation  with otCD3. Cellular  extracts were 
harvested,  CAT assays were performed,  and the percent  conversion  of 
[14C]chloramphenico1 to its acetylated forms was quantified using a Be- 
tagen Betascope. Within individual experiments,  the results were normal- 
ized to the - 199 WT induced level (100%), and then averaged and plotted 
in the disphyed histograms.  The SD is represented by the error bars. The 
figure shows the results of six independent  transfecrion experiments,  ex- 
cept for the 3'flank M and Spl M histograms, which summarize five inde- 
pendent experiments. (B) The x3 site is required for CsA-sensitive  induc- 
tion of the human TNF-ot promoter by ionomycin. The experiments were 
indicated  that the x3 element  was necessary for full induc- 
tion of the  -199 TNF-ol CAT fusion construct in response 
to c~CD3.  Inspection of the sequences between  -61  and 
- 27 n relative to the TNF-c~ cap site revealed an Spl binding 
motif (5'-CCCCGCCC-3') between  -53 and  -46 n rela- 
tive to the TNF-ot transcription start site (16). To determine 
whether these sequences were involved in the regulation of 
the gene by c~CD3,  the core nucleotides  of this site within 
the context of the  -199 TNF-c~  gene promoter were sub- 
stituted with the bases displayed in Fig.  5 C. Mutation of 
the Spl motif did not decrease basal or induced levels of CAT 
activity, but rather, resulted in an increase in the average levels 
of induction ("~140% of WT levels). Therefore, the decreased 
inducibility and relative CsA sensitivity displayed by the 5'M, 
YM,  and MM constructs  was specific to these base substi- 
tutions. 
Ca  2+  Ionophore.  Mutation  of the  g3  site  had  a much 
more pronounced effect on the ionomycin-mediated  induc- 
tion of the TNF-ot promoter. As displayed in Fig. 5 B, mu- 
tations  in either the 5' or 3' sequences of the g3 site (5'M 
and  YM)  essentially  abrogated  induction  by  ionomycin, 
whereas mutation of sequences in the middle of the g3 site 
(MM) significantly  decreased inducibility  to ~17% of WT 
levels. Mutation of the nudeotides flanking the 3' sequences 
of the K3 site (3' flank M) had a greater effect on ionomycin- 
mediated  induction  than  on  olCD3-mediated  induction, 
causing a decrease of "~30% in the absolute level of induc- 
tion of CAT activity. Mutation of the SP1 sequences did not 
decrease the inducibility or CsA sensitivity  of the promoter, 
but rather increased induced levels of CAT activity as previ- 
ously observed for otCD3. Thus, although promoter sequences 
in addition to K3 are involved in the induction of the  - 199 
TNF-c~  promoter/CAT fusion by c~CD3,  x3 plays a major 
role in its CsA-sensitive induction in response to ionomycin. 
Multiple  Copies of the K3 Promoter Element Confer 
CsA-sensitive Inducibility on a Minimal 
TNF-ar Promoter 
To further characterize the function of the K3 element and 
to determine whether K3 could function as a discrete regula- 
tory dement,  Ar-5 cells were transfected with a construct 
in which multimers of g3 were placed upstream of a min- 
imal TNF-ot promoter fused to CAT. The control construct 
containing the minimal TNF-ol promoter (-61 to  + 89 n) 
was minimally inducible by oeCD3 (approximately twofold) 
(Fig. 6 A, lanes 1 and 2). In contrast,  a construct that con- 
rained six copies of the K3 dement upstream of -61 TNF-c~ 
CAT was dearly inducible by olCD3 (approximately  seven- 
fold) and this augmented induction was blocked by CsA (Fig. 
6 A, lanes 4-6). The K3 multimers also conferred ionomycin 
inducibility on the minimal TNF-o~ promoter (from '~3-15- 
performed as in (A), except that the ceUs were induced  with 1/~M  ionomycin 
in the presence or absence of CsA as indicated.  The results of three inde- 
pendent  transfection experiments  are shown. (C) A diagram of the base 
substitutions introduced into the x3 or Spl sites. (Boxes) The K3 and Spl 
sites. 
1370  Novel CsA-sensitive  Element in Human TNF-<x Gene Promoter Figure 6.  Six copies of ~3 act as an otCD3 or ionomycin 
inducible, CsA-sensitive promoter element when fused to a 
minimal TNF-oe promoter in Ar-5 T cells. (,t) Autoradio- 
gram shows results of CAT assays of extracts prepared from 
At-5 cells transfected with the plasmids diagrammed.  Cells 
were transfected and either mock induced (-) or induced with 
o~CD3 for 18 h in the presence or absence of CsA as indi- 
cated. The x3 oligomer contains  -106 to  -87 n relative to 
the TNF-~x cap site and a BamHI and BgllI linker at its 5' 
and 3' ends, respectively.  The (r,3)6-61TNF-ot  construct is de- 
scribed in Goldfeld et al. (16). (B) Autoradiogram shows the 
results of CAT assays of extracts from cells transfected with 
the plasmids diagrammed (A) that were induced with 1 #M 
ionomycin  for 18 h in the presence or absence of CsA as indi- 
cated. CsA was added 10 min  before stimulation  with o~CD3 
(A) or ionomycin (B). The results are representative of four 
independent  experiments. 
fold) that was blocked by CsA (Fig. 6 B, lanes 4--6). In con- 
clusion, this analysis indicated that r,3 sequences are sufiicient 
to mediate CsA-sensitive transcriptional induction in response 
to  c~CD3  or  ionomycin.  When  the  K3  multimers  were 
fused to a heterologous promoter (-128/3-globin),  they did 
not confer either inducibility or CsA sensitivity on the CAT 
reporter gene (data not shown).  Therefore,  the K3 element 
behaved in T cells as an c~CD3, calcium-inducible, and CsA- 
sensitive transcriptional promoter element in the context of 
its  own minimal  TNF-c~  gene promoter. 
Rapid Protein Synthesis-ind~endent  Induction  of a 
CsA-sensitive  /:3 Binding  Factor(s) 
in Stimulated  T  Cells 
TCR Stimuli.  To further characterize the K3 element and 
to test whether g3 could bind to an inducible, CsA-sensitive 
nuclear factor in stimulated T cells, nuclear extracts were pre- 
pared from At-5 cells that had been stimulated with olCD3 
in the presence and absence of CsA for the various times in- 
dicated in Fig. 7 A.  Using the K3 oligonucleotide spanning 
the sequences from  -106 to  -87 n relative to the TNF-ot 
Figure 7.  Induction of nuclear K3 binding  comple~es by aCD3. Gel shift experiments with nuclear extracts from stimulated and unstimulated  At-5 
T cells using chemically synthesized r.3 oligonucleotide as a probe. (A) Kinetics and CsA sensitivity of induction  of the x3 binding  complexes. Nuclear 
extracts were prepared from Ar-5 T cells that had been induced with otCD3 for the times indicated (rain) in the presence (+) or absence (-) of CsA. 
(Arrows) The two inducible protein-DNA complexes (Upper and Lower). (B) Insensitivity of the induction of the x3 binding complexes to protein 
synthesis inhibitors.  Nuclear extracts were prepared from At-5 cells that had been induced with o~CD3 for the times indicated in the presence (+) 
or absence  (-) of the protein synthesis  inbAbitors  cycloheximide  (C/-/X) and anisomycin  (ANIS). CHX/ANIS was added 30 man  before induction  with oeCD3. 
1371  Goldfeld et al. Figure  8.  Ionomycin  induces the K3 binding complexes in Ar-5 nuclear extracts.  Gel shift experiments  were performed using the K3 and  -61 to 
-27 n oligonucleotides  as probes.  (A) At-5 cells were mock (-) induced  or induced  with 1/~M ionomycin or 100 nM ionomyein  as indicated  for 
30 min and nuclear extracts  were prepared.  Treatment  with 1/zM ionomycin  results in the appearance of the upper  and lower ~3 binding complexes 
(compare lanes I  and 2).  100 nM of ionomycin results in the appearance of the lower complex but not the upper complex (lane 3). The  - 61 to  - 27 n 
probe binds  to a constitutive factor  that is not induced  by ionomycin  (lanes 4-6).  (B)  Ionomycin  induction the ~3 binding complex is blocked by 
CsA and does not require de novo protein synthesis.  Nuclear extracts  were prepared from Ar-5 cells that were mock induced  (-), treated with CsA 
alone, or CHX/ANIS alone, or induced  with 1/~M ionomycin  in the presence or absence of CsA or CHX/ANIS as indicated.  The nuclear extracts 
were bound to the g3 oligonucleotide  or the  -61 n  to  -27 n  oligonucleotide  as indicated. 
mRNA cap site in an EMSA, two inducible complexes (Fig. 
7, upper and lower) were detected. These complexes were ap- 
parent within 15 min of activation by cxCD3 (Fig. 7, lanes 
1 and 3), and were maximally  induced at 30 min after stimu- 
lation (Fig. 7, lane 5).  By 4 h after olCD3  induction, the 
upper complex was barely detectable (Fig. 7, lane 11), whereas 
the intensity of the lower complex was significantly decreased 
(Fig. 7, lane 11). Induction of  both inducible complexes was 
completely  blocked at all time points by pretreatment of the 
cells with CsA (Fig. 7, lanes 4,  6,  8,  and 10). 
To determine whether  induction of  the r3 binding factor(s) 
required prior protein synthesis, nuclear extracts from At-5 
cells that had been induced with oeCD3 for various times 
in the presence and absence of protein synthesis inhibitors 
were tested. As shown in Fig. 7 B, de novo protein synthesis 
is not required for induction of K3 binding activity since cy- 
cloheximide and anisomycin did not prevent or delay the ap- 
pearance of r3 binding activity after o~CD3 induction (Fig. 
7, lanes 3 and 4). We conclude that the K3 element specificaUy 
binds  to  an aCD3-inducible,  CsA-sensitive,  protein syn- 
thesis-independent factor(s) that is induced within minutes 
of T cell activation. Thus, the inducible binding characteris- 
tics of the K3 binding factor(s) are entirely concordant with 
the requirements for induction of  TNF-o~ gene transcription. 
As an internal control for specificity of binding and pro- 
tein loading in the experiments displayed in Fig. 7, we tested 
the same nuclear extracts in an EMSA using an oligonucleo- 
tide spanning  the sequences  -61  to  -26 n relative to the 
TNF-c~ mtLNA cap site (-61 to  -27 n) as a probe. As ex- 
pected from the functional data demonstrating that these se- 
quences were not primarily involved in the o~CD3 CsA- 
sensitive induction of the TNF-ol gene, the expression of a 
constitutive factor binding these sequences  were not increased 
by o~CD3, or affected by treatment with CsA or protein syn- 
thesis inhibitors  (data not shown). Therefore, the inducible 
CsA-sensitive binding activity in these nuclear extracts was 
detected specifically  using the K3 oligonucleotide as a probe. 
Furthermore, the SP1 binding motif that occurs within the 
sequences spanning  -61 to -27 n was shown to be involved 
in the constitutive binding to the  -61 to  -27 n probe as 
an excess  of  nonradiolabeled wild-type oligonucleotide  com- 
peted for binding, whereas an oligonucleotide containing a 
1372  Novel CsA-sensitive Element in Human TNF-c* Gene Promoter Figure 9.  Specificity  of  binding of the K3 binding complexes.  Nuclear 
extracts from cells that had been induced  for 30 min with c~CD3 were 
bound to 32p endlabded  K3 oligonucleotide  alone (lane  I) or in the pres- 
ence of a 500-fold excess of unlabeled K3 (lane  2), K1 (lane  3), g2 (lane 
4), PRDII (lane 5), NF-xB (WT) (lane 6), MS' (lane 7), M3' (lane 8), 
or NFAT  (lane  9) oligonucleotides.  The sequences  of  the oligonucleotides 
are detailed  in Materials and Methods. 
mutation in the Sp1  site did not  (data not shown).  Thus, 
the sequences spanning  -61  to  -27  n  specifically  bind to 
a constitutive factor that  may be Sp1. 
Ca  2+  Ionophore.  Nuclear  extracts  from At-5  cells  that 
had been stimulated with the calcium ionophore ionomycin 
for 15 min were also tested for the presence of g3 binding 
activity. As demonstrated in Fig. 8 A,  the inducible upper 
and lower x3 binding complexes were apparent in nuclear 
extracts from cells treated with 1/~M of ionomycin but not 
in nuclear extracts from uninduced cells (Fig.  8, lanes I  and 
2).  A  lower concentration of ionomycin (100 nM) slightly 
induced the lower complex (Fig. 8, lane 3). The equivalence 
of protein loading and the specificity of ~c3 inducible binding 
was confirmed by using the same extracts to bind to the - 61 
to  -27  n  probe  (Fig.  8,  lanes 4-6). 
Furthermore, ionomycin-mediated  induction of the upper 
and lower g3 binding complexes was blocked by CsA (Fig. 
8 B, compare lanes 2 and 4) and was unaffected by protein 
synthesis inhibitors (Fig. 8, lane 6). Again the -  61 to  - 27 n 
probe  bound  to  a  constitutive  factor whose binding  was 
unaffected under these conditions (Fig. 8, lanes 7-12). Thus, 
as in the case with c~CD3  induction, ionomycin-inducible 
binding of the K3 binding factor(s) paralleled TNF-o~ mRNA 
induction by ionomycin. 
Characterization of the/c3 Binding Factor(s) 
The Jc3 Binding Factor Is  Distinct from  NF-/cB  but May 
Resemble NFAT.  To establish that the inducible K3 binding 
complexes bound specifically to the x3 sequence, the ability 
of nuclear extracts from stimulated T  cells  to bind to  the 
radiolabeled K3 oligonucleotide in the presence of an excess 
of unlabeled ~3 competitor oligonudeotide was tested. Un- 
labeled K3 oligonudeotide competed for binding to both the 
upper and lower complexes (Fig.  9, lanes I-2), whereas oli- 
gonucleotides corresponding to the two other NF-gB con- 
sensus sites in the TNFoc~ promoter, K1 and K2, which are 
not involved in the induction and CsA sensitivity of the gene 
(see Fig. 3), did not compete for binding (Fig. 9, lanes 3 and 4). 
Previous studies (16) employing human B cell nuclear ex- 
tracts had demonstrated that K1, K2, and K3 specifically bound 
a  complex that  could be competed by an oligonucleotide 
matching the murine Ig x chain enhancer NF-KB  site, but 
not by an oligonucleotide that was mutated in three guanine 
residues absolutely required for NF-xB binding. Therefore, 
whereas K1, x2, ~3, and the Ig K chain enhancer NF-KB site 
are all capable of binding to the same protein in B cells, the 
g3 binding factor appears  specific for the K3 site alone, con- 
sistent with the unique role of this site in the induction of 
the TNF-c~ gene in activated T cells. Subsequent studies es- 
tablished that ~3 does not form any DNA-protein complex 
with purified p50/p65 NF-~B (data not shown), indicating 
that the x3 binding factor is distinct from the p50 homodimer 
or the pS0/p65  NK-KB  heterodimer. The K3 site can bind 
to proteins in cellular extracts from Ntera cells  transfected 
with c-rel and p50 (54,  55), however, the complex formed 
migrates with different mobility from the x3 binding com- 
plex (data not shown). Moreover, antibodies to c-tel, pS0, 
and p65 (56) do not react with the K3 binding complex de- 
tected in nuclear extracts from Ar-5 cells  stimulated with 
c~CD3  or ionomydn or from Ar-5 cytosolic extracts (data 
not shown). We conclude that the g3 binding complex in 
activated T  cells does not contain c-rel, pS0, or p65,  and is 
thus distinct from NF-xB. 
Other studies employing nuclear extracts from stimulated 
T  cells  showed that  an NFAT-like factor bound to  the Ig 
K  chain enhancer NF-KB site, and this binding involved residues 
at the 3' end of the KB site (49).  To determine whether the 
g3 binding factor might be related to this NFAT-like factor, 
a competition analysis was done with Ig NF-KB and NFAT 
oligonucleotides. Oligonucleotides matching the wild-type 
Ig K chain enhancer NF-KB site (WT),  and the NF-xB site 
from the IFN-~ gene (PRDII) competed for binding of the 
K3 binding factor. However, an Ig NF-IcB oligonucleotide 
that was mutated in three guanine residues absolutely required 
for NF-KB  binding (27) also  competed for binding to  the 
g3 oligonucleotide (MS', Fig. 9, lane 7), whereas an oligonu- 
cleotide mutated in the 3' residues was no longer able to com- 
pete for binding (M3  ~ Fig. 9, lane 8). This pattern of compe- 
tition was identical to that seen for the binding of the NFAT 
related factor to the Ig NF-gB site (49), and suggested that 
the K3 binding factor was related to NFAT. Consistent with 
this, an oligonucleotide matching the distal NFAT site from 
the murine IL-2 gene promoter competed for binding to the 
g3 binding factor (Fig.  9,  lane 9). 
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Binding Complexes Suggests that the Same Sequences Required 
for In  Vivo Activity Participate in the Formation of Both Com- 
plexes.  To determine whether the upper and lower K3 binding 
complexes contracted different bases of the x3 oligonucleo- 
tide, a methylation interference analysis using nuclear extracts 
from ionomycin-stimulated  Ar-5 cells was performed. Both 
the 5' and 3' sequences of the site contacted DNA-binding 
proteins (Fig. 10). Specifically, methylation of the three gua- 
nine residues in the 5' end of the K3 element (relative to the 
coding strand) substantially interfered with binding of the 
upper complex (Fig.  10, compare lane 2 with lanes I  and 
3), whereas methylation of two of the three guanines in the 
3' end of the site eliminated binding of the upper complex 
(Fig.  10, compare lane 7 to lanes 6 and 8).  For the lower 
complex, methyhtion of the same 5' and 3' nudeotides resulted 
in partial interference with binding (Fig.  10, compare lane 
4 with lanes 3 and 5 and lane 9 with lanes 8 and 10). Similar 
results were obtained using nuclear extracts that had been 
stimulated with c~CD3 (data not shown). Methylation also 
interferes with binding to sequences which flank the 5' nucleo- 
tides (see noncoding strand, ATGAG), indicating that these 
sequences may also be involved in the binding of the upper 
and lower complexes.  In conclusion, the same 5' (TGGG) 
and 3' (CTCC) nudeotides that are crucial for the TCR- and 
ionophore-mediated induction of the TNF-ol promoter are 
also crucial for the binding of the upper and lower K3 binding 
complexes to the g3 oligonucleotide. Moreover, this analysis 
indicates that both the upper and lower x3 binding complexes 
bind with similar recognition properties to the g3 oligonu- 
cleotide. These complexes may therefore contain the same 
inducible nudear factor,  and the difference in mobility be- 
tween the two complexes may be due to differential modifi- 
cation and/or association  with a different nuclear factor. 
Figure 10.  Methylation interference  analysis shows that the 5' and 3' 
nucleotides are involved in binding of both the upper and lower g3 binding 
complexes. (~p) A comparison of cleavage patterns of methylated g3 oli- 
gonucleotide bound to the upper or lower complex. The g3 oligonucleo- 
tide was labeled on the coding strand (hnes I-5) or the noncoding strand 
(lanes 6-10)  and methylated. Nuclear extracts from Ar-5 cells that had 
been induced with 1/~M ionomycin for 30 min were incubated with the 
methylated probe. Free and bound probes were then isolated, cleaved with 
piperidine, and analyzed on a 12%  denaturing gel. Fragments that are 
underrepresented in the bound probe as compared to the free probe result 
from cleavage  at guanine residues whose methyhtion interferes with binding. 
(Free) Unbound oligonucleotide; (upper and lower) oligonucleotide  bound 
to complexes corresponding to the upper and lower complexes in the EMSAs 
displayed in Fig. 9, A and B. (Bottom) Summary of the methylation inter- 
ference analysis for the upper and lower compk~es. The g3 site is shown 
with the coding strand on top in the 5' to 3' orientation for both the 
upper and lower complexes. (Closed  circles) Nudeotides whose methylation 
interferes with binding; (open  circles)  positions at which methylation resulted 
in partial interference. 
The/c3  Binding Factor Preexists in  Unstimulated T  Cells 
The rapid induction of the ~3 binding factor and its inde- 
pendence from de novo protein synthesis suggested that it 
is present in unstimulated Ar-5 cells. Since specific K3 binding 
activity was not detected in nuclear extracts  from unstimu- 
lated At-5 cells (Fig.  7, A  and B, lanes I  and 2), cytosolic 
extracts  from unstimulated cells were tested for K3 binding 
activity. As shown in Fig. 11, the g3 oligonudeotide  specifically 
bound to a protein(s) in cytosolic extracts from unstimulated 
Ar-5 cells. The radiolabeled g3 oligonucleotide formed two 
specific complexes that migrated similarly to those seen when 
nuclear extracts from stimulated T cells were used (compare 
to Figs.  7 and 9).  Thus, the g3 binding factor preexists  in 
unstimulated At-5 cells, either sequestered in the cytosol or 
in an inactive form that can be extracted from the nuclei of 
unstimulated cells under our extraction conditions. 
Furthermore, the level of x3 binding factor proteins in the 
cytosolic extracts decreased by 2>65% after stimulation with 
ionomycin, and, pretreatment of the cells with CsA blocked 
this decrease (Fig.  11 B, lanes 1-3).  However, when we em- 
ployed the  -61  to  -27 n probe and tested its binding to 
these extracts,  we also detected a decrease in binding after 
induction by ionomycin (Fig. 11, lanes 4-6), whereas a probe 
matching the AP1 site from the murine collagenase  gene bound 
a protein that did not decrease after induction (Fig. 11, lanes 
7-9). The binding complexes formed by the  -61 to  -27 n 
and AP1 probes may represent proteins that are leached from 
the nucleus during the preparation of cytosolic extracts. This 
is commonly observed for a variety of nuclear proteins in- 
cluding rb (57) and ets proteins (58).  Therefore, although 
1374  Novel CsA-sensitive  Element in Human TNF-c~ Gene Promoter Figure  11.  (A) The K3 binding factor  is present in cytosolic  extracts from unstimulated  T cells. Unstimulated  Ar-5 cells were lysed  in hypotonic 
buffer containing  NP-40, and the soluble proteins were concentrated  by ammonium  sulfate  precipitation. After  resuspension  and dialysis,  the proteins 
were assayed  in an EMSA  for binding  to the g3 oligonucleotide.  Two specific  complexes,  designated  upper and lower  (arrows), bind to the K3 oligonucleo- 
tide. The binding of these complexes was competed  by an excess of unlabeled K3 (lane 2), but not by xl or x2 (lanes 3 and 4). (B) The K3 binding 
factor decreases in cytosolic  extracts from cells stimulated  by ionomycin.  Cells were unstimulated  (UN) or stimulated  with 1/~M ionomyein  for 30 
min (+) in the presence or absence of CsA, and cytosolic  extracts  were  prepared as described  in (A). The proteins were assayed  in an EMSA for binding 
to the x3 oligonucleotide  (lanes I-3),  the  -61 to  -27 n oligonucleotide  (lanes 4-6) and the AP1 oligonucleotide  (lanes 7-9). 
we have demonstrated that the g3 binding factor is detected 
in the cytosolic fraction of unstimulated T cells and appears 
rapidly in nuclear extracts upon stimulation, we cannot con- 
dude definitively that there is a translocation of the K3 binding 
factor from the cytosol to the nucleus in stimulated T  cells. 
Immunofluorescence  experiments using antibodies to purified 
K3 binding protein will be required to resolve this question. 
Discussion 
Induction  of the  Endogenous  TNF-cr  Gene  in  Murine  T 
Cells.  We have demonstrated that the TNF-c~ gene is one 
of the earliest genes induced in T  cells  activated by TCR 
ligands. TNF-ol mRNA levels  increase strikingly  within 15-30 
min of exposure of a murine T cell done to activating anti- 
bodies against the TCR-CD3 complex. This increase reflects 
an increase  in TNF-e~  gene transcription as judged by the 
commensurate increase in CAT activity in transient transfec- 
tion assays using human TNF-o~ promoter CAT fusion plas- 
mids. The transcriptional activation of the TNF-ol gene is 
not dependent on de novo protein synthesis, since pretreat- 
ment of the cells with protein synthesis inhibitors has no 
effect on the kinetics or magnitude of TNF-c~  mRNA ex- 
pression. Thus, in contrast to genes encoding most other lym- 
phokines and lymphokine receptors,  including IL-2, whose 
transcription is dependent upon de novo protein synthesis 
(for reviews see references 59 and 60),  the TNF-ot gene be- 
haves as an immediate early gene in activated T  cells. 
Induction of the TNF-ot gene in Ar-5 T cells is mediated 
by a calcium-dependent pathway since it occurs in T  cells 
stimulated with calcium ionophore alone. Moreover, induc- 
tion does not require the ol and B isozymes of protein kinase 
C, since it occurs efficiently in cells that have been depleted 
of these isozymes by prolonged treatment with the phorbol 
ester PDBu (data not shown). These data again differentiate 
the induction requirements of the TNF-c~ gene from those 
of other activation-related genes such as IL-2, whose tran- 
scription requires  both the protein kinase C  and calcium- 
mediated signals (36, 61) and is abolished by protein kinase 
C depletion (46, and Goldfeld, A. E., P. G. McCaffrey, and 
A. Rao, unpublished observations). However, the induction 
of  TNF-c~ gene transcription resembles the induction of other 
lymphokine genes in that it is completely blocked by the im- 
munosuppressive agents CsA and FKS06. 
The/c3 Element Is an crCD3 and Ionophore-inducible Promoter 
Element in Activated Murine T-cells.  The region between - 118 
and  -87 n  of the human TNF-oL gene promoter contains 
a previously identified NF-xB consensus sequence,  g3. Site- 
directed mutagenesis of x3 within the context of the  - 199 
TNF-o~ promoter decreased but did not obliterate o~CD3 in- 
1375  Goldfeld  et al. duction, suggesting that although K3 is a key element, other 
sequences  participate in  TCR-mediated induction of the 
TNF-c~ promoter. In contrast, ionomycin induction appeared 
to be primarily mediated through the g3 element as muta- 
tion of the 5' or 3' nucleotides almost entirely obliterated 
the promoter's inducibility. The specificity of this effect is 
confirmed by the observation that the mutation of other se- 
quences within the promoter did not decrease the promoter's 
inducibility or CsA sensitivity. 
A  Preexisting K3 Binding Factor Is a Target  for CsA.  The 
protein(s) binding to the K3 element, the K3 binding factor, 
preexists in unstimulated T cells. Although its location cannot 
be definitively established in the absence of antibody reagents, 
it is absent from nuclear extracts of unstimulated T cells, but 
is present in cytosolic extracts from unstimulated T cells. This 
indicates that it either normally resides in the cytoplasm of 
unstimulated cells or that it is extracted from nuclei of un- 
stimulated cells under our extraction conditions. In either 
case, binding of the K3 binding factor to the g3 element in 
nuclear extracts requires a modification event that occurs upon 
T  cell activation. It is rapidly detected (within 15 min) in 
nuclear extracts  from T cells stimulated by aCD3 or iono- 
mycin. Furthermore, induction of the g3 binding factor is 
completely concordant with induction of TNF-c~ gene ex- 
pression itself: neither process requires de novo protein syn- 
thesis and both can be totally blocked by pretreatment with 
CsA. Taken together, these data suggest that TCR stimula- 
tion and the ensuing increase in intracellular calcium activate 
the ~c3 binding factor by causing its posttranslational modifi- 
cation and/or translocation to the nucleus, and that the nu- 
clear K3 binding complex participates in TNF-o~ gene induc- 
tion. The rapid disappearance of the K3 binding factor from 
nuclear extracts after induction may reflect its recycling back 
to the cytoplasm, inactivation, or degradation. The g3 ele- 
ment thus represents a novel cyclosporin-sensitive regulatory 
element and the first example characterized  in a gene other 
than IL-2. 
Relationship of the/c3-Binding  Factor to other Transc@tion 
Factors.  Despite the resemblance  of the K3 element to an 
NF-KB binding site (16), the p50/p65 NF-~cB heterodimer 
and/or c-rel are not part of the ~c3 binding complex. First, 
the K3 element does not bind to purified pS0/p65 NF-gB 
in an EMSA. Second, the appearance of the p50/p65 NF-KB 
heterodimer in nuclear extracts  of activated Ar-5 T  cells is 
not inhibited by CsA at 30 min after activation, and is only 
partially inhibited at 2 h (49, and McCaffrey, P. G., and A. 
Rao, unpublished results). In contrast, the nuclear induction 
of the K3 binding complex is completely blocked by CsA in 
all time points tested. Third, an oligonucleotide that is mu- 
tated in the 5' guanines crucial for binding of the pS0/p65 
NF-KB heterodimer competes for binding to the g3 binding 
factor. Finally, antibodies to p50, p65, or c-tel have no effect 
on the mobility of the K3 binding complex. Thus, the K3 
binding factor is distinct from p50/p65 NF-gB and does not 
contain c-rel. 
The K3 binding factor is dearly distinct from the factors 
oct-1 and OAP-40 (44), which bind to the NFIL2A site of 
the IL-2 promoter. Although the induction of multimers of 
the NFIL2 site is blocked by CsA and FKS06 (37), their max- 
imal induction requires stimulation with both phorbol ester 
and ionophore, whereas the g3 multimer constructs are in- 
ducible by ionomycin alone. The oct-1 protein is constitu- 
tively expressed in nuclear extracts  of unstimulated T  cells 
and its binding is not affected by CsA or FK506 (37). Fur- 
thermore, the octamer-associated protein OAP-40, although 
inducible in a gel shift assay, requires protein synthesis for 
its induction (44). 
The relationship of the K3 binding factor to the factor 
binding to the NFAT site of the ILo2 promoter remains to 
be elucidated. This factor, also termed NFAT, consists of a 
preexisting subunit (NFATp) present in cytosolic extracts of 
unstimulated T cells (41-43, 62), which associates with los 
and jun proteins in the nuclei of activated T cells (42). The 
preexisting NFATp subunit resembles the g3 binding factor 
in that its appearance in nuclear extracts of activated T cells 
can be induced with calcium ionophore, does not require de 
novo protein synthesis,  and is completely blocked by CsA 
(41-43,  62-64). Previous studies have shown that NFATp is 
a substrate for calcineurin, the serine/threonine phosphatase 
whose activity is inhibited by CsA-cyclophilin and FKS06- 
FKBP complexes (43). The data presented here indicate that 
the g3 binding factor may also be a calcineurin substrate. 
The NFAT site shares no clear sequence similarity with 
the K3 element, other than being pyrimidine rich. However, 
factors related  to NF-ATp are capable of binding to several 
NF-gB sequence motifs (49),  and we have shown that the 
murine IL-2 NFAT oligonucleotide is able to compete with 
g3 for binding. It is therefore possible that the K3 binding 
factor may be a member of a closely related family of tran- 
scription factors resembling NF-ATp, that undergo a shared 
calcium-dependent, CsA-sensitive  posttranslational modifi- 
cation step. Alternatively,  NFATp itself could be a part of 
the K3 binding complex. 
In conclusion, the TNF-c~ gene represents a new model 
system for the study of those signal transduction events after 
T cell activation that results in CsA-sensitive inducible gene 
transcription.  The  protein  product  of the  TNF-a  gene 
cooperates in the differentiation and proliferation of B and 
T cells (4, 5, 65), the generation of dendritic Langerhans cells 
(66), and is capable of inducing latent HIV-1 into a produc- 
tive infection (7, 67). Recent studies have demonstrated that 
TNF-a plays a critical role in superantigen-triggered lethal 
shock mediated by T cells (68),  and elevated TNF-a levels 
are associated with renal and cardiac allograft rejection (69, 
70) and several infectious diseases (71). Therefore, in addi- 
tion to providing insight into the molecular events that follow 
lymphocyte activation, and mechanisms of inducible gene tran- 
scription, these studies could have a practical  impact upon 
the modulation by immunosuppressants of TNF-oe levels in 
transplant medicine, lymphoproliferative  disorders, and other 
disease states. 
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